Later this month, leading scientists and cutting-edge thinkers will gather at the International AIDS Society’s 9th IAS Conference on HIV Science in Paris to discuss the latest scientific discoveries in HIV prevention, care and treatment. These discoveries hold the potential to accelerate progress toward the global 90-90-90 targets set forth by the Joint United Nations Programme on HIV/AIDS (UNAIDS). And, they are especially important for key populations — including men who have sex with men, sex workers, transgender people and people who inject drugs — who shoulder a disproportionate burden of HIV. UNAIDS estimates that 45 percent of all new HIV infections among adults worldwide occur among these key populations and their sex partners. Reaching these groups with new technologies and approaches is essential to ending the epidemic.
Now, more than ever, is a time to stand up for science. The U.S. administration’s proposed budget for fiscal year 2018 calls for severe cuts to several key science-generating institutions, including the U.S. National Institutes of Health, the U.S. Centers for Disease Control and Prevention, the U.S. Agency for International Development and the U.S. Environmental Protection Agency. These cuts would result in a deterioration of the science that has allowed the United States to be the global leader in medicine, public health and environmental science. They would also stall progress in global development, an area which has benefited greatly from the many lifesaving solutions produced through science.
Given the administration’s apparent disregard for science, we should take a step back and ask ourselves what may seem like a simple question: What is science and why does it matter? Of the many definitions, the most basic is the standard dictionary definition: a systematically organized body of knowledge on a particular matter. More importantly though, science is a process or way of thinking that seeks to reveal the “truth.” Not knowing the truth about something is like driving through a heavy fog. Science can cut through this fog and reveal the truth.
Every year, the International AIDS Society (IAS) holds the largest open scientific conference on HIV and AIDS-related issues. This year’s conference, IAS 2017, will take place in July in Paris. FHI 360 is a media partner with IAS 2017, and in the lead-up to this year’s conference, we are coordinating Facebook Live conversations with experts who will be speaking there.
One U.S. expert who will present at the conference is Dr. Anthony Fauci, Director of the U.S. National Institute of Allergy and Infectious Diseases. Dr. Fauci was recently in Washington, DC, to speak at the annual meeting of the HIV Prevention Trials Network. After his plenary talk, Dr. Fauci sat down with FHI 360’s Dr. Otto Chabikuli, Director of Global Health, Population and Nutrition, for a Facebook Live chat on the science of HIV. Dr. Fauci talked about his experience working in HIV research for more than 35 years, addressing issues such as what a cure for HIV might look like, the multiple ways to prevent HIV infection, treatment as prevention, and the projects that his team is currently working on.
The World Health Organization estimates that the current shortage of global health care workers is 7.2 million. Without intervention, this number will soar to 18 million by 2030. Rachel Deussom, an FHI 360 expert on the health workforce and Senior Technical Officer, Human Resources for Health, Health Systems Strengthening, hosted a conversation with other FHI 360 colleagues to examine the shortage, its underlying causes and potential solutions.
The full version of this post originally appeared on R&E Search for Evidence. Reposted with permission.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is a remarkable success story built on the effective use of data. The achievements of this landmark initiative have played a central role in getting us to the point where we can finally talk about controlling the HIV epidemic and creating an AIDS-free generation.
Through 2016, US$70 billion has been invested in this unprecedented disease control effort. The accomplishments to date have been extraordinary and unimaginable just a few years ago: In 2016 alone, 74 million people were tested for HIV infection; since the start of PEPFAR, 2 million babies were born HIV-free due to women receiving prevention of mother-to-child HIV transmission (PMTCT) treatment; 12 million voluntary medical male circumcisions have been performed; and PEPFAR accounted for 12 million of the 18 million people globally receiving life-extending antiretroviral therapy (ART).
Over the past 15 years, we have witnessed major declines in child and maternal mortality and progress in the fight against HIV, tuberculosis and malaria in countries around the world. Still, an estimated 5.9 million children under 5 died in 2015, mostly from preventable causes. That same year, 2.1 million people became newly infected with HIV, and an estimated 214 million people contracted malaria.
In this podcast, I speak with Dr. Muhammad Ali Pate, an eminent physician and CEO of Big Win Philanthropy, an independent foundation that invests in children and young people in developing countries to improve their lives and to maximize demographic dividends for long-term economic growth.
An Interview with
Mary Mittochi, Project Director, DREAMS: Malawi Communities Investing in Education for Child Health and Safety, FHI 360
In this Q&A, Mary Mittochi, the project director for DREAMS: Malawi Communities Investing in Education for Child Health and Safety, discusses how this new project will reduce the acquisition of HIV by adolescent girls and boys. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) named FHI 360 as one of the winners of the DREAMS Innovation Challenge. The DREAMS partnership, led by PEPFAR with support from the Bill & Melinda Gates Foundation, Girl Effect, Johnson & Johnson, Gilead Sciences and ViiV Healthcare, is helping adolescent girls and young women become Determined, Resilient, Empowered, AIDS-free, Mentored and Safe.
As one of the 56 DREAMS Innovation Challenge winners, how will FHI 360 help adolescent girls and young women become Determined, Resilient, Empowered, AIDS-free, Mentored and Safe?
FHI 360’s DREAMS: Malawi Communities Investing in Education for Child Health and Safety project will focus on integrated, community-led efforts designed to ensure that education, health and economic drivers for staying in school and completing secondary education are simultaneously addressed and strengthened. Over time, this will reduce the incidence of HIV in adolescent girls and boys. By keeping girls in school and connecting them to a comprehensive range of services and supports, we aim to equip them and their communities with the knowledge and agency they need to make more informed choices about their health and their future.
Do investments in private hospitals and clinics catering to the wealthy strengthen primary health care systems in poor countries?
At a recent roundtable discussion in New York City, a representative of a private equity group presented plans to build private hospitals in emerging markets, such as Kenya, as one of the best ways to strengthen primary health care delivery. For most of us who have worked on strengthening health systems, investing in hospitals that cater to the well-off doesn’t sound like the best way to meet the health needs of the poor.